Home » Authors » Anette Breindl

Articles by Anette Breindl

Cord Blood Cells In Stroke Model Triumph Over Blood-Brain Barrier

Oct. 19, 2004

By Anette Breindl

Cord Blood Cells In Stroke Model Triumph Over Blood-Brain Barrier

Oct. 19, 2004

By Anette Breindl

New Horizons For Flu Seed Strain, Vaccine Production

Oct. 15, 2004

By Anette Breindl

New Horizons For Flu Seed Strain, Vaccine Production

Oct. 15, 2004

By Anette Breindl

From Embryonic To Adult: Recent Stem Cell Research

Oct. 12, 2004

By Anette Breindl

From Embryonic To Adult: Recent Stem Cell Research

Oct. 12, 2004

By Anette Breindl

Expression Profiling Hints At Fibrosis' Role In COPD

Oct. 11, 2004

By Anette Breindl

Expression Profiling Hints At Fibrosis' Role In COPD

Oct. 11, 2004

By Anette Breindl

From Cellular Trash To Receptor Families, Awards Season Arrives

Oct. 7, 2004

By Anette Breindl

From Cellular Trash To Receptor Families, Awards Season Arrives

Oct. 7, 2004

By Anette Breindl

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...